| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.033 | 0.5 |